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Peptide-directed crystal growth modification in
the formation of ZnO†
Anna Sola-Rabada,a Mei-Keat Liang,a Martin J. Roeb and Carole C. Perry*a
Biomolecule-mediated synthesis is fascinating in terms of the level of control and the intricate hierarchical
structures of the materials that can be produced. In this study we compare the behavior of a phage
display identified peptide, EAHVMHKVAPRP (EM-12) with that of a mutant peptide EAHVCHKVAPRP
(EC-12), having additional complexation capability, on the formation of ZnO from solution. The synthesis
conditions (Zn(CH3COO)2–NH3 hydrothermal method at 50 1C) were chosen to generate rod-shaped
ZnO via layered basic zinc salts (LBZs) as intermediates. Both peptides affected the crystal formation
process by moderating the amount of Zn2+ ions in solution (EC12 having a greater effect than EM12) but
only EC12 was shown to interact with the solid phase(s) formed during the reaction. Depending on the
peptide concentration used, EM-12 was shown to delay and/or suppress ZnO formation. In contrast,
additions of EC-12, although leading to the retention of higher levels of Zn2+ ions in solution did not
similarly delay the transformation of the intermediate phases to ZnO but were found to dramatically
modify the morphology of ZnO crystallites with mushroom shaped crystals being formed. From the
results of detailed materials characterization and changes in the morphology observed, the interactions
between the peptide(s) and solution and solid state species present during the process of ZnO crystal
formation in the presence of EM-12 and EC-12 are proposed.
Introduction
The identification of biomineral-associated biomolecules has shed
light on how biominerals are formed in living organisms. This has
also led to the use of the bioinspired/biomimetic approach for
materials synthesis,1–4 even for non-biologically produced minerals
such as ZnO.5 Despite ZnO not being found in living organisms,
to date, more than twenty ZnO-binding peptides (ZnO-BPs)
have been identified from either cell surface display6,7 or phage
display libraries.8–11 However, only a few peptides such as
GLHVMHKVAPPR (G-12),12,13 EAHVMHKVAPRP (EM-12)9,14
and derivatives GLHVMHKVAPPR-GGGC (GT-16)12,15 and
EAHVMHKVAPRP-GGGSC (ET-17)9,15 have been studied further.
The addition of GT-16 during ZnO synthesis has been shown to
reduce the aspect ratio of the ZnO crystals formed.8 In order to
unravel the cause(s) of aspect ratio reduction by this ZnO-BP, our
group conducted some studies using G-1212,13 and/or GT-16.12
The direct evidence obtained suggested that (i) ZnO aspect ratio
reduction occurs via an adsorption-growth inhibitionmechanism,
(ii) G-12 adsorbing on both (0001) and (10%10) planes of ZnO is
sufficient to reduce ZnO aspect ratio (GGGC-tag is not essential);
and, (iii) that the GGGC-tag is responsible for the selective
adsorption of GT-16 on the (0001) plane of ZnO crystals. Also,
the addition of G-12 in different ZnO experimental systems led
to a modification of the growth mechanisms.13 Studies by
others have shown that the addition of ET-17 into stable
Zn(OH)2 sols catalyzes ZnO formation, directing a flower-type
anisotropic crystal growth.9 The catalytic effect of ET-17 is
generated either by the presence of the EM-12 segment or
GGGSC-tag.9 The catalytic effect of ET-17 was further confirmed
as ET-17 attached to a genetically modified-collagen template
was able to generate ZnO nanowires.16 A study proposed to
understand the interactions taking place between the ZnO
surface and EM-12 showed that conformational changes as well
as charged amino acids and residues adjacent to the charged
aminoacids are critical to the binding to ZnO.17 It was concluded
that the electrostatic interaction between ZnO particles and
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ZnO-BPs was enthalpy-driven, and involved hydrogen bonding,
as also suggested by Patwardhan et al.18 The specific binding
sites of the EM-12 peptide have been explored,19 with the shorter
sequences; HVMHKV and HKVAPR having either high specificity
and/or affinity for ZnO nanoparticles. Additionally, it was
proposed that ZnO binding did not depend on hydrophobicity
or other physical parameters but ZnO recognition of the specific
amino acid alignment of these peptides.19 Morphology changes
observed for ZnO growth in the presence of ZnO-BPs did not lead
to random morphologies. For example, the addition of EM-12 or
dipeptides from its sequence (i.e. Met–His or His–Lys) during
solution synthesis using Zn(OH)2 as a precursor, suppressed
crystal growth of ZnO in the (0001) direction.14
The coordination of Zn2+ with proteins plays an important role
for the structural stability and functionality of proteins in living
organisms as evidenced inmetalloproteins such asmetallothionine
and zinc fingers of DNA-binding proteins.20 Zn2+–protein complexa-
tion occurs at specific domain(s) via the side chains of amino acid
residues namely; sulphur atoms of cysteine and methionine,
nitrogen atoms of histidine, and oxygen atoms of aspartic acid
and glutamic acid.20 In experimental studies using a Zn(NO3)2–
HMTA hydrothermal reaction, Gerstel et al. demonstrated that the
presence of aspartic acid, glutamic acid, and their corresponding
dipeptides produced layered basic zinc salts (LBZs) as opposed to
the expected ZnO.21 They also observed the formation of soluble
complexes when higher concentrations of these additives were
used and proposed that Zn2+-additive complexation via electrostatic
interaction was responsible for LBZs or soluble complex for-
mation.21 More recently, it has been shown that the presence of
peptides with different isoelectric points (in the acid, basic and
neutral range) using a Zn(NO3)2–NaOH hydrothermal reaction
also formed LBZs as a metastable phase during the precipita-
tion process. It was suggested that negatively charged peptides
intercalated easily in metastable LBZs.22
Previous studies have shown that the formation of ZnO
(without additives) occurs via intermediate(s), LBZs, that only later
transform to the oxide phase (ZnO).23–29 This crystallization process
usually occurs by a phenomenon known as Ostwald’s Law of
phases30 in which a metastable phase is formed prior to the
formation of the stable phase. In a recent study conducted by
our group, the ZnO growth mechanism without the presence of
additives has been described and compared for two different
hydrothermal methods: (a) zinc acetate (Zn(CH3COO)2) and
ammonia (NH3) and (b) zinc nitrate hexahydrate (Zn(NO3)2
6H2O) and 1,3-hexamethylenetetramine (HMTA).
31 Both synth-
esis routes supported the growth of twinned hexagonal rods.
However, the progression of solid phase transformation from
LBZs to ZnO showed a dissolution/reprecipitation process
in the Zn(CH3COO)2–NH3 system, which did not occur for
Zn(NO3)26H2O–HMTA system.31
In the current study, the eﬀect of the peptides EM-12 (identi-
fied by phage display) and EC-12‡ during ZnO formation was
investigated using a Zn(CH3COO)2–NH3 hydrothermal method.
32
A specific aim of the investigation was to explore the effect of
increasing number of potential complexing groups on ZnO
formation, for instance, the replacement of methionine (M5)
with cysteine (C5) in the peptide sequence.
Results and discussion
Delay/suppression of ZnO Formation by EM-12
The role of EM-12 in aﬀecting ZnO formation was explored by
characterization of the precipitates and analysis of components
present in solution at a series of reaction times. Previous studies
have shown that the formation of ZnO occurs via intermediate(s),
layered structures that only later transform to the oxide phase
(ZnO).23–29 In this system (ZnAc2–NH3), the intermediate com-
pounds have been identified as Layered Basic Zinc Acetate
(LBZA)23–29 and Layered Basic Zinc Acetate Carbonate
(LBZAC)27,28,31 with formulae, Zn5(OH)8(CH3COO)22H2O and
Zn5(OH)x(CH3COO)y(CO3)znH2O (x + y + z = 10), respectively.
Based on the characterization of the 24 hour precipitates using
XRD and SEM (Fig. 1), the addition of 0.1 mM of EM-12 (Zn-to-
peptide ratio = 150 : 1) did not affect ZnO formation signifi-
cantly. This was inferred from the observation of hexagonal
rods (Fig. 1a(i)) and the detection of characteristic diffraction
peaks of ZnO (Fig. 1a(i)) at 31.981, 34.631, and 36.481 assigned
to the (10%10), (0002), and (10%11) planes, respectively.9,25,33
However, in the presence of EM-12 at higher concentrations,
either a delay or suppression of ZnO formation was observed.
In the presence of 0.2 mM EM-12 and above (Fig. 1a(iii)–(vi)), a
layered structure with irregular shapes was observed, with the
main diffraction peak at 6.86  0.031, attributed to the (001)
plane of LBZA32–34 with an interlayer spacing of 12.94  0.05 Å.
This is in agreement with previously reported interlayer spacing
values of B12–15 Å for LBZA.25,29,35,36 The presence of LBZAC
was discounted as 00l reflections would have had a larger
interlayer spacing (B19 Å) produced by the co-intercalation of
both acetates and carbonate ions.27,28 For samples with 0.2 mM
and 0.3 mM of peptide, the detection of ZnO as the major
component was delayed to 48 hours (Fig. 1b(iii)–(iv)). This effect
will be referred to as ‘‘delayed-formation’’ hereafter. In the
presence of 0.4 mM EM-12, both LBZA and ZnO were detected
in the sample at 48 hours (Fig. 1b(v)) and for the highest EM-12
concentration studied; 0.5 mM, LBZA remained the major phase
at 48 hours (Fig. 1b(vi)) suggesting the suppression of ZnO
formation. The change in the twinning behavior of ZnO crystals
(SEM images, Fig. 1b) with increasing EM-12 concentration was
also observed, and will be discussed later in this article.
The delayed-formation of ZnO was also supported by sub-
jecting the precipitates to thermal decomposition (TGA) which
resulted in three stages of weight loss (Fig. 2a); first, the release
of physisorbed water at temperatures below 100 1C.25,29 Second,
the dehydration of intercalated water (100 1C–168 1C) and/or the
dehydroxylation of zinc hydroxide layers in LBZA (168 1C–250 1C).
Finally, the decomposition of acetate groups at temperatures
from 250 to 400 1C.25,29 Total weight loss values of 31–38% have
been reported for LBZA in the literature.26,29,31,37 In this study,
‡ EM-12, 12-mer peptide containing methionine; EC-12, 12-mer peptide contain-
ing cysteine.
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the weight losses observed in the presence of 0.2 mM EM-12
and above, supported the presence of LBZA in the samples
(Fig. 2b). The reduction in weight loss from 24 to 48 hours
was due to the phase transformation from LBZA to ZnO. For
the highest concentration of peptide studied; 0.5 mM, LBZA
remained the major phase up to 168 hours (B34%) (Fig. 2b).
Hence, the addition of 0.5 mM suppressed ZnO formation to the
extent that LBZA remained stable up to 168 hours while lower
EM-12 concentrations only slowed down the rate of conversion
of LBZA to ZnO (Fig. 2b).
Further evidence for the various phases came from XPS
analysis of precipitated material. The survey spectra showed
the presence of Zn, O and C in all the precipitates studied
(Blanks, 0.2 mM and 0.4 mM of EM-12), with peaks in the
Zn 2p3/2, O 1s and C 1s regions; having BE values of 1021.7 
0.2 eV, 531.6  0.1 eV, 285.0  0.0 eV, respectively; (Fig. 3). From
the plot of % area of the C 1s and Zn 2p3/2 peaks at diﬀerent
concentrations of peptide, an increase of the C 1s region with
peptide addition can be observed (Fig. 3) supporting the
Fig. 1 XRD diﬀractograms of precipitates collected in the presence of
diﬀerent concentrations of EM-12 at (a) 24 hours and (b) 48 hours. The
diﬀraction peak arising from the aluminum sample holder is marked with
an asterisk (*). d denotes the interlayer spacing of LBZA formed. The
corresponding SEM images of the precipitates are shown. All scale bars
shown are 5 mm and (i) to (vi) correspond to Blank, 0.1 mM, 0.2 mM,
0.3 mM, 0.4 mM and 0.5 mM of EM-12, respectively.
Fig. 2 (a) Representative TGA 1st derivative weight loss curves of pre-
cipitates collected at 24 and 48 hours with [EM-12] of 0 mM (Blank) and
0.2 mM; and (b) total weight loss (%) of precipitates collected in the
presence of diﬀerent concentrations of EM-12 (0.1–0.5 mM) at 24 hours,
48 hours and 168 hours (0.5 mM EM-12 only). The starred bars correspond
to samples that are mainly LBZA as observed by XRD.
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supposition that the presence of EM-12 slowed down the rate of
conversion of LBZA to ZnO, as more C is expected with the
presence of the intermediate. Even though the data obtained
include traces of ‘‘adventitious carbon’’, usually present in the
XPS experiment (ESI 1†), the remaining carbon was thought to
be from LBZA, as identified by XRD and TGA and further
evidenced by the analysis of core-level spectra for Zn 2p3/2, C
1s and O 1s regions, Fig. 4. The presence of Zn metal was
discarded in our system as the Zn LMM peak was shown to be at
988.4 eV attributable to ZnO,38 whereas the kinetic energy peak
for metallic Zn would be expected at 992 eV.38 The diﬀerent local
chemical states of each element in the precipitates indicated the
presence of such element in a mixed environment, as is the case
for LBZA with formula Zn5(OH)8(CH3COO)22H2O. The peak
position values, the full width half maximum (FWHM) and its
identification are given in ESI 2.†
ZnO formation in the ZnAc2–NH3 system goes through
several intermediates: LBZA and LBZAC.23–29,31 It is believed that
the acetate groups in LBZA are gradually replaced by carbonate
groups originating from dissolved CO2 present in solution, hence a
new intermediate can be observed, LBZAC. At the later stages of
ZnO formation (i.e. 48 hours) carbonate species can be dominant
over acetate species, albeit in traces amounts relative to the
amount of ZnO present.31 Although XRD data did not show the
presence of these intermediates, traces of carbonates and acetates
were detected by FTIR, Fig. 5. For the sample prepared in the
presence of 0.2 mM EM-12, the peaks identified were similar to
those for the Blank, and arose from traces of carbonate species
present in the sample even though ZnO was the dominant
compound detected by XRD. For the highest concentration of
peptide studied, 0.5 mM, characteristic acetate peaks were
detected (Table 1), confirming the delayed-formation of ZnO. This
effect (delay-formation) can be due to either EM-12 stabilized LBZA
or retained Zn2+ ions in solution; in both cases LBZA is favored
and is discussed in more detail later in this paper.
Zn2+-EM-12 complexation and delayed/ suppression of ZnO
formation
The presence of EM-12 extended the period where LBZA was
stable as the intermediate phase, delaying or suppressing the
formation of ZnO. According to Gerstel et al.,21 amino acids
having side chain functionality that interact electrostatically
with Zn2+ in solution or on a crystal seed interface, would
impose a strong influence on the morphology or the type of
precipitate formed.21 Since amino acids capable of complexing
with Zn2+, such as glutamic acid, histidine and methionine, are
present in EM-12, they may reduce the amount of free Zn2+
in solution available for ZnO formation. Thus, the delay/
suppression of ZnO formation was hypothesised to be linked
with changes in the amount of Zn2+ in solution when EM-12
Fig. 3 (a) XPS survey spectrum recorded from an as-deposited precipitate
collected at 24 hours with [EM-12] of 0.4 mM and (b) atomic % of carbon
and zinc for the 48 hour precipitate with 0.0 mM (Blank), 0.2 mM and
0.4 mM of EM-12.
Fig. 4 High resolution core level spectra of an as-deposited precipitate
collected at 24 hours with [EM-12] of 0.2 mM for (a) Zn 2p3/2, (b) O 1s and
(c) C 1s.
Fig. 5 FTIR of 48 hour precipitates collected at diﬀerent concentrations of
EM-12. The identification of the peaks (i) through to (v) is given in Table 1.
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was present. This was confirmed frommeasurement of the Zn2+
concentration in the supernatants using ICP-OES. As previously
mentioned, in this particular system (ZnAc2–NH3) the progres-
sion of solid phase transformation from LBZs to ZnO goes
through a dissolution/reprecipitation process in which precipi-
tation of LBZA occurs immediately after mixing of reagents.31
The dissolution process takes place within 16 hours of reaction
when Zn2+ are released back into solution, hence showing an
increase of Zn2+ over time, followed by stabilization of Zn2+ in
solution after 24 hours of reaction.31 As shown in Fig. 6a, this
phenomenon is also observed in the presence of EM-12.
The addition of EM-12 increased the % of Zn2+ (%Zn2+) in
solution throughout the reaction (Fig. 6a and b). For data
analysis, t = 1 hour was used to represent the stage where LBZA
was the major phase and t = 96 hours to represent equilibrium.
The increase of %Zn2+ with respect to the Blank for these two
selected time points (D%Zn2+t=1h and D
%Zn2+t=96h) was calculated
(Fig. 6c). D%Zn2+t=1h and D
%Zn2+t=96h increased as a function of
EM-12 (initial) concentration. The increase of %Zn2+ in the
presence of EM-12 started from the early stages of reaction while
a positive correlation was observed between D%Zn2+ and EM-12
concentration. These two observations suggest that EM-12
stabilized high concentrations of Zn2+ in solution with the
stabilization starting from the beginning of the reaction.
If the higher concentration of Zn2+ present in solution was due
to Zn2+ and EM-12 complexation, retention of EM-12 in solution
would also be expected. The concentration of EM-12 in solution
was measured using UV spectrometry. Absorbance calibration
curves of the ZnAc2–NH3 system and for the peptides; EM-12
and EC-12, are available in ESI 3.† Almost complete retention of
EM-12 in solution throughout the reaction was observed, (Fig. 7a),
implying that either EM-12 only interacts with Zn2+ species in
solution or interacts weakly (i.e. van der Waals forces) with zinc
species in the solid phase (LBZs/ZnO), being released back into
solution when a small force is applied to the system (such as
centrifugation). The retention of EM-12 in the solution was
further supported using FTIR analysis, since the spectra of
24 hour lyophilized precipitates did not show the characteristic
peak of the amide-I band of EM-12 (Fig. 7b), in contrast to the
behavior of EC-12 which will be discussed later.
Comparison with EC-12; a peptide with higher complexation
capability
Up to this point, the delay formation eﬀect shown by the addition
of EM-12 to the ZnO-forming reaction was very diﬀerent from the
ZnO catalytic eﬀect shown by GGGSC-tagged EM-12.9,16 This
diﬀerence is believed to be due to the additional GGGSC tag
present. Based on the side chain pKas calculated using Marvin,
41
the charges of EM-12 and EC-12 side chains at pH 7.0  0.1 (ESI
4†) are summarized in Table 2. For simplicity, only charges
involving at least 50% ionization of the side chain of a peptide
residue are shown. Over this narrow range of pH values, the side
chain and termini charges of both peptides are nearly identical
and their net charges are the same. Although only E1 and P12 are
anionic, other residues such as histidine (H), cysteine (C), and
methionine (M) are able to coordinate with Zn2+.20,42,43 Histidine
can bind to metal ions through its imidazole Ne2 or Nd1 and
become a bridging ligand when present in its deprotonated state.
Although cysteine binds to metal ions most frequently in its
deprotonated cysteinate form (i.e. deprotonated thiol group), a
neutral cysteine is able to serve as a ligand in ferrous heme iron
while non-deprotonable methionine can bind through its
Table 1 FTIR absorption peaks identified in precipitates collected at diﬀerent reaction times
Peak Wavenumber (cm1) Assignment
i B1620 O–H vibrational mode of the hydroxide slab in LBZA24,25 and/or O–H bending mode of water.39
ii B1550 Antisymmetric stretchinga (nas) of CO2
 25,27,40
iii B1505 Antisymmetric stretching (nas) of CO3
2 27,39
iv B1390 Symmetric stretching (ns) of CO2
 25,27,40 and/or n3 of CO3
2 27,39
v B1340 In-plane bending (ds) or deformation of CH3
27
a The carbonate group has two n3 modes assigned to the nas of CO3
2 band.27
Fig. 6 %Zn2+, the percentage of Zn2+ in solution with respect to the initial
Zn2+ concentration, for diﬀerent EM-12 concentrations: %Zn2+ as a function
of reaction time (a) up to 96 hours and (b) up to 7 hours, and (c) D%Zn2+,
the diﬀerence between %Zn2+ for the EM-12 added reaction and the blank,
at t = 1 hour (%Zn2+t=1h where LBZA was the major phase, grey triangle
symbols) and t = 96 hours (%Zn2+t=96h at equilibrium, circle symbols).
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sulphur lone pair.20 Thus, it is conceivable that these two
peptides are able to form complexes with Zn2+ thereby retaining
more Zn2+ in solution than is possible in their absence. Since
cysteine is known to be a stronger Zn2+ binder to Zn2+ com-
pared to methionine,20 EC-12 was expected to retain more Zn2+
in solution compared to EM-12.
As anticipated, the addition of EC-12 to the ZnAc2–NH3 reac-
tion under identical conditions retained more Zn2+ in solution
throughout the reaction compared to EM-12 and the increase was
proportional to the concentration of the EC-12 added (ESI 5†). In
the presence of EM-12 (0.1–0.5 mM),B36–42% andB46–50% of
Zn2+ was retained in solution at t = 1 hour and t = 96 hours,
respectively; compared to 34% and 45% for the Blank. In the
presence of EC-12 at comparable concentrations, B37–47% of
Zn2+ was retained in solution at t = 1 hour while 48–57% was
retained at t = 96 hours. The higher Zn2+-complexation capability
by EC-12 may be caused either by cysteine being a stronger
binder compared to methionine and/or by the difference in the
conformation of the peptides in solution. The comparison
of structures simulated in water at 300 K (GROMACS, force
field: GROMOS95, dt: 0.002 ps, total time: 2 ns)45 using Visual
Molecular Dynamics (VMD)46 in Fig. 8 showed that EM-12 (red
structure) and EC-12 (blue structure) have a highly superimpo-
sable C-termini segment (same peptide sequence). However, the
structure of EM-12 containing methionine at position 5 is more
compact than EC-12 having a cysteine at position 5, even though
their side chain functionalities are highly similar. It is also
possible that the more extended glutamic acid (marked by a
black arrow in Fig. 8) at the N-terminal having an anionic side
chain may contribute to the higher complexation of Zn2+ in
solution with EC-12 compared to EM-12.
In contrast to complete retention of EM-12 in solution through-
out the reaction (Fig. 7a), 40–75% of the added EC-12 was absent
from the solution at the beginning of the reaction (Fig. 9a). The
complete retention of EC-12 in solution occurred withinB7 hours
of reaction for the 0.1 mM EC-12 precipitate, B24 hours for 0.2–
0.3 mM EC-12 and B30 hours for 0.5 mM EC-12. In agreement
with the different starting time points for complete retention, the
amide-I band (FTIR) could be detected for the 24 hour precipitates
when higher concentration of EC-12 were added (Fig. 9b), but not
when EM-12 was added (Fig. 7b).
The detection of EC-12 in the precipitate was also shown by
XPS. The sample with 0.4 mM EC-12 was chosen for analysis
due to the prior detection of peptide by FTIR. The XPS survey
spectrum, Fig. 10a, was similar to that observed when studying
EM-12 (Fig. 3a); however, it not only showed the presence of Zn,
O and C, but also N. The high resolution core level spectrum of
the N 1s region gave a peak at 399.6 eV (Fig. 10b), attributed
to the presence of amino groups in the peptide (399.0 0.3 eV).22
The C 1s core level region also showed a peak at 286.5 eV,
Fig. 10c, corresponding to the tertiary carbon connected with the
nitrogen atom of the amino group,47–49 which was not detected
in precipitates containing EM-12 (Fig. 4c).
Fig. 7 (a) From UV-Vis, EM-12 concentration, [EM-12], in supernatants
collected at diﬀerent reaction time from reactions with initial [EM-12] of
0.1 mM, 0.2 mM, 0.3 mM, 0.4 mM and 0.5 mM and (b) FTIR spectra of
lyophilized precipitates collected at 24 hours. The peak arising with an
asterisk (*) is attributed to the O–H vibrational mode (corresponding to the
hydroxide slab in LBZA).24
Table 2 The charges of EM-12 and EC-12 side chain functional groups
calculated using Marvin44 at pH 7.0  0.1 at 298 K
EM-12 Sequence E1 A2 H3 V4 M5 H6 K7 V8 A9 P10 R11 P12 Net charge
Side chain charge  + + +
Terminal charge + 
EC-12 sequence E1 A2 H3 V4 C5 H6 K7 V8 A9 P10 R11 P12 Net charge
Side chain charge  + + +
Terminal charge + 
Fig. 8 Visualization of the superimposition of molecular structures
(simulated in water at 300 K) for EM-12 (EAHVMHKVAPRP) in red, EC-12
(EAHVCHKVAPRP) in blue, and G-12 (GLHVMHKVAPPR) in orange; images
generated using VMD.46
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Further, a broad peak was observed in the S 2p region, which
could arise from the cysteine thiol group50 present in EC-12.
The broad peak at around 162.2 eV (Fig. 11) was deconvoluted
into two peaks, 2p3/2 and 2p1/2 at 161.8 and 163.0 eV, respec-
tively. The S 2p doublet separation could be fitted using a peak
area ratio of 2 : 1 and a separation of 1.18 eV. The overlap of the
two peaks was most likely due to the small amount of sulphur
in the samples. Previous studies have showed that the binding
energy of the S 2p3/2 signal determines the presence of sulphur
as a thiol (unbound) or thiolate (bound to the surface), the BE
values being at B163 eV and B162 eV, respectively.47,48,50–52
Our data suggests that the interaction of EC-12 with the solid-
phase was via Zn2+–sulphur (from cysteine). Despite the presence
of a sulphur atom in both peptides, methionine for EM-12 and
cysteine for EC-12, the higher complexation capability of EC-12
seems to be at least in part due to the presence of the thiol group
in cysteine.
From the characterization of the 24 hour precipitate formed
in the presence of EC-12, ZnO was the main crystalline phase
detected by XRD (ESI 6†). However, as the weight loss of this
precipitate by TGA was 25%, the experimental data suggests
that LBZA was also present in the solid phase. Thus, the precise
solid phase(s), LBZA and/or ZnO, with which EC-12 interacted,
cannot be uniquely identified. Based on XRD and TGA results
(ESI 6†), the higher complexation capability of EC-12 did not
lead to a stronger delay/suppression eﬀect than EM-12 on ZnO
formation when higher concentrations of peptide were added.
From comparison of the % thermal decomposition weight loss,
generally all 24 hour precipitates obtained in the presence of
EC-12 contained a higher fraction of ZnO (weight loss B25%)
compared to those obtained in the presence of EM-12 (weight
lossB34%), and no ZnO suppression eﬀect was observed at the
highest EC-12 concentration employed (Fig. 12). However, a
weaker but still delayed-formation of ZnO due to the presence
of EC-12 was remarkably caused when lower concentrations of
EC-12 were used (ESI 4†). That EC-12 is able to interact with
species in solution and also with species in the solid state is the
key to this behavior. According to Umetsu et al., ET-17 could
catalyze ZnO formation from a stable Zn(OH)2 sol.
9 Although
EC-12 did not demonstrate any catalytic capability as shown by
ET-17, its weaker delay/suppression eﬀect on ZnO formation
(compared to EM-12) suggests the possibility of there being a
Fig. 9 (a) EC-12 concentration, [EC-12], in supernatants collected
at diﬀerent reaction time from reaction with initial [EC-12] of 0.1 mM,
0.2 mM, 0.3 mM and 0.5 mM from UV-vis measured (b) FTIR spectra of
precipitates collected at 24 hours.
Fig. 10 (a) XPS survey spectrum recorded from an as-deposited precipitate
collected at 24 hours ([EC-12] at 0.4 mM) and the corresponding high
resolution core level spectra of (b) N 1s and (c) C 1s regions.
Fig. 11 XPS high resolution core level spectra of the S 2p region.
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balance between a catalytic eﬀect and a delay/suppression eﬀect
by the modification of EM-12 through the incorporation of a
cysteine residue in the peptide. This (eﬀects tuning) possibility
cannot be discounted because (i) EM-12, EC-12 and ET-17 have
the same/highly similar combination of amino acid side chain
functionalities and (ii) any structural diﬀerences arising from
peptide sequence may be used to tune the strength of these
eﬀects. In terms of crystal morphology (Fig. 12), ZnO crystals
formed at 24 hours were mostly twinned but asymmetrical.
Crystals formed in the presence of 0.1–0.2 mM EC-12 have more
defined facets (Fig. 12a and b) while those formed at higher EC-12
concentrations assumed the shape of mushrooms (Fig. 12c and d).
When the reaction was extended to 48 hours, the asymmetrical
crystals developed into more symmetrical crystals with smaller
diameter at their twinned planes, having either a dumbbell
shape (Fig. 12e and f) or an hourglass-like shape (Fig. 12g
and h). It is noticeable that these ZnO crystals were morphologi-
cally different from those obtained from the Blank reaction that
had uniform diameters along their c-axes.
Eﬀects of EM-12 and EC-12 on ZnO morphology
In the presence of EM-12, ZnO crystals generally transformed
from symmetrical twinned ZnO crystals (Blank) to asymmetric
twinned crystals (in the majority) followed by un-twinned
crystals as EM-12 concentration was increased from 0.1 mM
to 0.4 mM, Fig. 13(a)–(c) and Scheme 1a. The aspect ratio was
studied for all ZnO containing precipitates and showed the
reduction of L/D with the addition of peptide (Fig. 14). For the
Blank (0 mM of EM-12) the points are overlapped due to
the symmetrical hexagonal rods and for [EM-12]Z 0.3 mM only
one value is given due to the crystal growth equilibrated before/at
the end of growth of the first rod. Further, EM-12 not only
caused the delayed formation of ZnO (conversion from LBZA
to ZnO) but also caused the inhibition of crystal growth as
seen in Fig. 14 (inset), where the Blank increased its aspect ratio
with time and for samples containing EM-12 the aspect ratio
was maintained over time. In the presence of EC-12, a similar
trend to the Blank was observed, which suggested that addition
of EC-12 did not lead to an inhibition of crystal growth as seen
for EM-12.
ZnO crystals generated in the presence of EC-12, Scheme 1b,
were diﬀerent from those obtained in the presence of EM-12
in three aspects. Firstly, all crystals remained twinned as the
Fig. 12 SEM images of precipitates collected at (a) 24 hours (scale bars =
5 mm, inset scale bars = 1 mm) and (b) 48 hours (scale bar = 2 mm). EC-12
concentration for SEM images are (i) 0.1 mM for (ii) 0.2 mM, (iii) 0.4 mM and
(iv) 0.5 mM.
Fig. 13 SEM images of precipitates collected at 48 hours for: (a) 0.1 mM,
(b) 0.2 mM, and (c) 0.4 mM of EM-12. All scale bars are 5 mm and inset scale
bars at 0.5 mm.
Scheme 1 The illustration of ZnO morphology (principal) in the presence
of (a) EM-12 at diﬀerent concentrations (based on 48 hour-precipitates)
and, (b) EC-12 at diﬀerent concentrations collected after 24 hours and
48 hours. Non-scaled images are for morphology comparisons only.
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EC-12 concentration was increased. Secondly, the diameter of the
crystals was not uniform along their c-axis. Thirdly, the surface
planes of the crystals became less well-defined with increasing
EC-12 concentration with mushroom-like ZnO crystals being
obtained in the presence of higher concentrations of EC-12.
It has been proposed that twinned hexagonal rods are
formed by the aggregation of two approximately spherical
particles.53 However, the observed morphology changes (with
time) in the presence of EC-12 suggest that crystallization
occurred by the formation of the first hexagonal rod (R1st)
followed by the growth of the second rod (R2nd) on the first
one.15 Note that with the increase of EC-12 the hexagonal
rods became spheres (S1st and S2nd). It is believed that EM-12
added reactions follow the same mechanism. It has been
reported that the reduction of the aspect ratio on crystals can
be due by specific polypeptides playing a role in the competitive
adsorption-nucleation process by interacting with specific
crystal planes15 and for ZnO, theoretical and experimental
studies,12,15 have suggested that polypeptides can interact with
the (0002) plane corresponding to the c-axis with a reduction in
the aspect ratio being observed; however, in this current
work, the changes in twinning behavior with increasing amount
of EM-12 can be explained as follows. Zn2+-EM-12 complexation
reduced the amount of Zn2+ available for crystal growth. At
lower EM-12 concentrations (0.1–0.2 mM), the growth of the
second rod (R2nd) was not complete resulting in the formation
of asymmetrically twinned ZnO crystals. In the presence of
0.3 and 0.4 mM EM-12, crystal growth equilibrated before/at the
end of growth of the first rod (R1st), thus, untwinned ZnO
crystals were obtained, which was supported by the observation
of untwinned crystals being shorter but having comparable
diameters with those (larger side of asymmetrical twinned
crystals) formed at lower EM-12 concentrations (Fig. 14).
Addition of R2nd can be considered as a secondary nucleation
process15 which in this case was inhibited by the presence
of EM-12.
The ZnO morphology transformation (from dumbbell to
mushroom-like) by increasing EC-12 concentration is believed
to be due to interaction with the solid-phase. This peptide may
have modified the ZnO morphology via reversible adsorption
on ZnO crystals.54 The adsorption of G-12 (GLHVMHKVAPPR),8
a highly similar ZnO-BP (67% and 58% similar to EM-12 and
EC-12, respectively), has been shown to reduce the aspect ratio
of ZnO crystals via an adsorption-growth inhibition mechanism
by interacting with Zn2+ and/or O2 on ZnO surfaces.12 The
diﬀerences and similarities between the eﬀects of EM-12, EC-12
and G-12 on ZnO crystal morphology and formation may have
arisen (i) at least partly from the presence of glutamic acid (E)
in EM-12 and EC-12 but not in G-12; (ii) their superimposable
C-termini, (iii) superimposable N-termini between EC-12 and
G-12, and (iv) the extended structure of EC-12 in solution as
opposed to the more compact structure of EM-12, Fig. 8.
The modification of ZnO morphology via the reversible
adsorption of EC-12 on ZnO crystals cannot be confirmed due
to the presence of other solid phase(s), LBZs. The interlayer
spacing of LBZA formed in the presence of EC-12 did not
change significantly compared to the Blank (ESI 6†) which
implied that either EC-12 was not intercalated or it was oriented
parallel to the zinc hydroxide layer while intercalated. Thus, the
possibility of EC-12 intercalating into LBZA formed and then
released back into the solution during LBZA conversion to ZnO
cannot be discounted.
A recent study has shown that some common amino
acids can be incorporated into the ZnO lattice,55 particularly,
amino acids containing S or Se, as is the case of cysteine and
selenocysteine, respectively. Subsequently, it was found that
incorporation of the amino acids led to a change in the optical
and paramagnetic properties of the material as well as the
crystal morphology. The possibility that EC-12 could have been
incorporated into the lattice of ZnO was studied, ESI.† ZnO
lattice strain modification was observed when EC-12 was added
into the system further suggesting the possibility of this peptide
being incorporated into the lattice of ZnO.
Experimental
Materials and methods
Reagents. Zinc acetate (Zn(CH3COO)2), piperazine (C4H10N2),
N,N-diisopropylethylamine (DIPEA, C8H19N), trifluoroacetic acid
(TFA, C2HF3O2), thioanisole (C7H8S), 3,6-dioxa-1,8-octanedithiol
(DODT, C6H14O2S2), 1 M hydrochloride acid (HCl), zinc atomic
absorption standard solution (1000 ppm), 1 M potassium hydro-
xide volumetric standard (KOH), acetonitrile (ACN) and sodium
chloride (NaCl) were purchased from Sigma-Aldrich; ammonia
solution (NH3, 35%), ethanol (C2H6O), N,N-dimethylformamide
(DMF), dichloromethane (DCM),N-methyl-2-pyrrolidinone (NMP),
and diethyl ether were purchased from Fisher Scientific; O-benzo-
triazole-N,N,N0,N0-tetramethyl-uronium-hexafluoro-phosphate
Fig. 14 Average aspect ratio (L/D) of ZnO crystal rods (n Z 30) as a
function of [EM-12] where large and small indicated on the legend
represent the larger or smaller crystal on each side of the twin plane.
The inset shows the L/D of entire ZnO crystals (n Z 30) as a function of
time for Blank, EM-12 and EC-12 samples.
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(HBTU) and all Fmoc-protected amino acids required for peptide
synthesis were purchased from CEM Corporation while the
proline-preloaded-TGT resins were obtained from Novabiochems.
All chemicals were used without further treatment. Distilled-
deionized water (ddH2O) with conductivity less than 1 mS cm
1
was used as the solvent for all ZnO synthesis reactions.
ZnO synthesis and kinetics studies. ZnO synthesis was
conducted in aqueous solution following a previously described
method32 in which twinned hexagonal rods were expected to
grow using 30 mM of Zn(CH3COO)2 (hereafter labeled as ZnAc2)
in 50 1C water and 31.25 mM of NH3. To avoid deviation of NH3
concentration from the target concentration by evaporation,
the concentration of a 5% NH3 solution used for stock solution
preparation was determined by titration prior to each experi-
ment. For all reactions, 24 ml of 31.25 mM of NH3 stock
solution at room temperature was vigorously stirred into
25 ml of 30 mM ZnAc2 solution (at 50 1C) followed by the
addition of 1 ml of the prepared peptide solutions; giving final
peptide concentrations in a range of 0–0.5 mM. The pH of the
reaction solutions were 7.0  0.1 regardless of the peptide
identity and the concentration of the peptide used. The mixtures
were placed in a water-bath set at 50 1C for up to 168 hours.
During the course of reaction, sample aliquots of 5 ml were
taken from the reaction vessels at 24 and 48 hours (2 minutes).
From detailed studies of the Blank reaction,31 ZnO was detected
as the major phase at 16 hours and beyond. Thus, times chosen
were to enable the formation of ZnO to be followed. Collected
samples were centrifuged at 13 000 rpm for 3 minutes to
separate precipitates from the supernatants. The precipitates
were washed three times with ddH2O. The supernatant
obtained was recentrifuged using the same conditions. This
supernatant was used for the determination of the concen-
tration of Zn2+ and peptide in the solution. Cleaned precipitates
and selected supernatants were lyophilized at 70 1C using a
Virtis-110 freeze-dryer.
Solid phase peptide synthesis. EM-12 and EC-12 were pre-
pared by solid phase methods using a microwave-assisted
solid phase peptide synthesizer (CEM Corporation) via Fmoc
chemistry.56 TGT resin preloaded with Fmoc-protected proline
was used as the solid support. The following side chain
protections were used: Pbf for arginine; Trt for cysteine and
histidine; OtBu for glutamic acid; and Boc for lysine. The
couplings, via a O-benzotriazole-N,N,N0,N0-tetramethyl-uronium-
hexafluoro-phosphate (HBTU) condensation agent, were single
except for arginine where a double coupling was used. The
cleavage of the peptide from the resin and the deprotection of
side chains were achieved in one step by treating the peptide
resin with a cleaving agent containing trifluoroacetic acid,
thioanisole, ddH2O, and 3,6-dioxa-1,8-octanedithiol (DODT).
The cleaved peptides were re-precipitated in chilled diethyl
ether and washed three times with the same solvent prior to
lyophilisation at 70 1C using a Virtis-110 freeze-dryer. The
purity of the lyophilized peptides was analyzed with a Dionex
HPLC equipped with a UV detector (set at 214 nm) and a Jupiter
4u Proteo 90A C12 Reverse Phase column (Phenomenex).
The purity of EM-12 and EC-12 was determined as 88% and
93% respectively. The mass to charge ratio (m/z) of the peptides
was measured using a Bruker UltraflexIII TOF/TOF mass
spectrometer and analysed with BrukerDaltonics flexAnalysis
software. The molecular weight (Mw) of EM-12 and EC-12,
1371.6 g mol1 and 1343.6 g mol1, respectively; was confirmed
with their measured m/z of 1371.8 m/z and 1343.7 m/z, respec-
tively (ESI 8†).
Characterization of lyophilized precipitates. The crystallinity
of the precipitates obtained was characterized using XRD
(PANalytical X’Pert PRO, Cu Ka radiation with wavelength of
1.54056 Å). Ground samples (if necessary) were packed into an
aluminium sample holder and scanned from 51 to 901 of 2y at
an accelerating voltage of 45 kV, 40 mA filament current, using
a scan speed of 0.021 s1 at room temperature. Diﬀraction
patterns were analyzed using X’Pert-HighScore Plus (Version
2.0a) program for diﬀractogram manipulation, background
determination and peak identification. The morphology and
size of selected precipitates were studied using SEM (JEOL JSM-
840A, 20 kV, gold sputter-coated samples). For ZnO crystal size
analysis, more than 30 crystals were studied for each sample
and the aspect ratio (L/D = length/diameter average) of each
individual crystal was determined using the Java-based image
processing program (ImageJ software). FTIR (Perkin Elmer
Spectrum 100 FTIR Spectrometer with Diamond/KRS-5 crystal
and Nicolet Magna IR-750) was used to detect the functional
groups present in the lyophilized precipitates. Spectra were
averaged from 32 scans at 2 cm1 resolution with air as back-
ground. The amount of non-ZnO component in the precipitates
was determined by thermogravimetric analysis, TGA (Mettler
Toledo TGA/SDTA 851e) where samples were heated at 101min1
from 30 1C to 900 1C in air to ensure complete combustion of
all organic material. The chemical constitution of the precipi-
tates was investigated by XPS using a VG Scientific ESCALab
MkII X-Ray photoelectron spectrometer with a Al Ka X-ray
source (hn = 1486.6 eV). Samples were ground and then
mounted on standard sample holders. Before analysis of the
samples, the calibration and linearity of the binding energy
scale was checked with a pure silver sample using the peak
positions of the Ag3d5/2 photoelectron line (at 368.26 eV) and
the AgM4NN Auger line (at 1128.78 eV). Survey spectra of
precipitates were collected covering the full binding energy
(BE) range from 0–1200 eV using a step size of 1 eV, a dwell
time of 0.2 seconds and a pass energy (PE) of 50 eV. High
resolution core level spectra of the Zn 2p3/2, C 1s, O 1s, N 1s and
S 2p peaks were collected using a PE of 20 eV, a step size of
0.2 and a dwell time of 0.4 seconds, which were subsequently
deconvoluted and fitted using standard mixed Gaussian–Lorentzian
components using CasaXPS software. To compensate for surface
charging effects in the insulating samples, all binding energies were
corrected with reference to the saturated hydrocarbon C 1s peak at
285.0 eV using the CasaXPS software.
Detection of peptide in supernatant. 200 ml of the super-
natant was diluted ten times with ddH2O, placed in a quartz
cuvette (10 mm path length), and scanned at 214 nm using
a Unicam UV2 UV-VIS spectrophotometer. The absorbance of
EM-12 or EC-12 in the supernatant was determined by subtracting
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the absorbance arising from ZnAc2 and NH3 from the absor-
bance of the supernatant. The absorbance of ZnAc2 at 214 nm
was estimated from the calibration curve for ZnAc2 absorbance
using [Zn2+] measured by ICP-OES while a constant absorbance
value was deducted for NH3. The concentration of EM-12 and
EC-12 were determined by comparing the absorbance of the
peptide against a series of calibration peptide solutions pre-
pared in the same medium (ESI 3†). FTIR-ATR (Perkin Elmer
Spectrum 100 FTIR Spectrometer with Diamond/KRS-5 crystal)
was used to detect the presence of amide-I and amide-II
bands of peptides in the lyophilized supernatants. Spectra were
averaged from 32 scans collected at 2 cm1 resolution with air
as background.
Detection of Zn2+ in the supernatant. 100 ml of the super-
natant was diluted a hundred times with 0.9% HCl solution
and the concentration of Zn2+ determined using ICP-OES,
Perkin Elmer Optima 2100DV. Standard solutions with known
concentrations were prepared in triplicate to generate the
calibration curve.
Conclusions
The eﬀect of the peptides EM-12 and EC-12 during ZnO
formation via the ZnAc2–NH3 reaction, showed that the
presence of the peptide EM-12 causes a delay and/or suppres-
sion of ZnO formation when the peptide concentration was
increased, with LBZA being the major compound present at
the highest concentration of EM-12 added. Further, the
presence of EM-12 not only caused the delayed formation of
ZnO (conversion from LBZA to ZnO) but it also caused the
inhibition of crystal growth (wurtzite structured hexagonal
rods) along the c-axis ((0002) plane). The presence of EC-12;
however, caused a more drastic change in the mineral morphology
with mushroom-like ZnO crystals being formed, and remark-
ably, no ZnO suppression was observed for the highest EC-12
concentrations added.
The data presented appears to show that the mechanism of
ZnO crystallisation occurs by the formation of a first hexagonal
rod (R1st) followed by the growth of a second rod (R2nd) on the
first one, considering the addition of R2nd as a secondary
nucleation process.
Experimental data showed that EM-12 interacts with Zn2+
species in solution, whereas EC-12 interacts either with Zn2+
species in solution and in the solid phase(s). Peptide inter-
action with the solid-phase cannot be observed when using
EM-12 although weak interactions cannot be discounted. The
EC-12 interaction mechanism is proposed to include Zn2+–
sulphur (from cysteine) interactions. Further, the reduction of
the amount of Zn2+ in solution in the presence of EM-12 was not
the only cause for the delayed/suppression of ZnO formation
in the ZnAc2–NH3 reaction, since a higher Zn
2+-EC-12 complexa-
tion compared with EM-12 was observed. ZnO lattice strain
modification was observed when EC-12 was added into the
system and it is suggested that this peptide may be incorporated
into the lattice of ZnO.
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